B3GNT2 and cystic fibrosis: For example, B3GNT2 (UDP‐GlcNAc:BetaGal Beta‐1,3‐N‐Acetylglucosaminyltransferase 2) has been identified as up‐regulated in patients with arterial disease while CF significantly down‐regulated its expression.